Summary In this paper the biochemical properties of the antigens detected by six murine monoclonal antibodies (MAbs) are described. These MAbs react selectively with the multidrug-resistant small cell lung cancer (SCLC) cell line, H69AR, compared to its sensitive parent cell line, H69 (Mirski & Cole, 1989 Resistance-associated proteins with the biochemical properties of the antigens described in this paper have not been reported previously and they remain potential markers for the as yet to be determined mechanisms of drug resistance in SCLC and other human malignancies.
In most patients with small cell lung cancer (SCLC) the effectiveness of chemotherapy is limited by the development of multidrug resistance (Niiranen, 1988) . Tissue culture models for this clinical problem include four adriamycin (ADM)-selected multidrug-resistant SCLC cell lines, H69AR, H69/LX4, H69/DAU4 and GLC4/ADR (Mirski et al., 1987; Twentyman et al., 1986; Jensen et al., 1989; Zijlstra et al., 1987) . Two of these cell lines, H69/LX4 (Twentyman et al., 1986) and H69/DAU4 (Jensen et al., 1989) , overexpress Pglycoprotein (P-gp+) (Reeve et al., 1989) , a plasma membrane protein which confers drug resistance by acting as an energy-dependent drug efflux pump to reduce the intracellular drug concentration (Bradley et al., 1988) . However, P-gp has been detected infrequently in SCLC tumours that have developed resistance to chemotherapy, suggesting that other mechanisms of resistance are likely to be more important in this disease (Lai et al., 1989) . The H69AR (Mirski et al., 1987) and GLC4/ADR (de Jong et al., 1990) cell lines, which do not overexpress P-gp (P-gp-), may therefore be particularly relevant to the study of multidrug resistance in SCLC. The molecular basis of the drug resistance in the H69AR cell line is still uncertain but is probably multifactorial. It is known, however,-that this cell line differs from the GLC4/ADR cell line because H69AR cells do not exhibit a drug accumulation defect (unpublished observation).
We have previously described six monoclonal antibodies (MAbs) that detect proteins that might be involved in the mechanism(s) of H69AR cell drug resistance (Mirski & Cole, 1989) . One of these antibodies, MAb 2.54, detects a cell surface epitope but does not affect the ADM sensitivity of H69AR cells (unpublished observation). It reacts with multiple proteins of 24.5-34.5 kDa on immunoblots and immunoprecipitates two proteins of 22.5 and 25.5 kDa. Non-cell surface, 100,000 x g membrane-associated epitopes are detected by the other five antibodies, MAbs 3. 50, 3.80, 3.177, 3.187 and 3.186 . MAbs 3.50 and 3.186 immunoprecipitate antigens of 55 kDa and 36 kDa, respectively, while MAbs 3.80, 3.177 and 3.187 all precipitate a 47 kDa protein. In this paper we present a further biochemical characterisation of the antigens with which these MAbs react in H69AR cells; in addition, we have examined the reaction of the MAbs with a panel of paired drug-sensitive and -resistant cell lines to determine whether these antigens are generally associated with multidrug resistance.
Materials and methods

Cell culture
The SCLC cell lines, H69, H128 and H209 were provided by Drs A. Gazdar and J. Minna (NIH, Bethesda, MD) . The MAR SCLC cell line was provided by Prof A.M. Neville (Ludwig Institute, London, UK) (Ibson et al., 1987) . The P-gp-multidrug-resistant variant of H69, H69AR, was obtained by stepwise selection in ADM and has been described previously (Mirski et al., 1987) . These cell lines were cultured in RPMI 1640 medium supplemented with either 5% foetal bovine serum (FBS) (GIBCO Laboratories, Burlington, Ont) or 5% defined/supplemented bovine calf serum (Hyclone Laboratories, Logan, UT). The H69/DAU4 cell line is a daunorubicin-selected multidrug-resistant variant of the human Jensen (Finsen Institute, Copenhagen, Denmark) . The H69/ LX4 cell line is an ADM-selected multidrug resistant variant of the human SCLC cell line H69 (Reeve et al., 1989) provided by Dr P. Twentyman (MRC, Cambridge, UK). The 2R50 and IR500-0 cell lines are ADM-selected multidrugresistant variants of the human squamous lung carcinoma cell line SW1573 (Keizer et al., 1989) . The 2R50 cell line is P-gp-while the IR500-0 cell line is P-gp+ (Dr F. Baas, Netherlands Cancer Institute, Amsterdam, personal communication). These cell lines were cultured in Ham's F-10 medium (Sigma Chemical Co., St. Louis, MO) supplemented with 10% FBS. HeLa-J2 is an ADM-selected P-gp-drugresistant variant of the human cervical carcinoma cell line HeLa-A6, provided by Dr R.M. Baker (Roswell Park Memorial Institute, Buffalo, NY; personal communication). These cell lines were cultured in alpha-minimal essential medium (a-MEM) (GIBCO) with 10% FBS. The MCF-7/MITOX cell line is a mitoxantrone-selected drug-resistant variant of the human breast cancer cell line, MCF-7, provided by Dr W.S. Dalton (Arizona Cancer Center, Tucson, AZ) (Taylor & Dalton, 1989) . The 2780/AD cell line is an ADM-selected multidrug-resistant variant of the human ovarian carcinoma cell line A2780/9S (Hamilton et al., 1985) . The MES-SA/ MX2 cell line is a mitoxantrone-selected P-gp+ multidrugresistant variant of the human uterine fibrosarcoma cell line MES-SA provided by Dr W.G. Harker (University of Utah, Salt Lake City, UT) (Harker et al., 1990) . The HT1080/DR4 cell line is an ADM-selected P-gp-multidrug-resistant variant of the human fibrosarcoma cell line HT1080 (Slovak et al., 1988) . The 8226/R40 cell line is an ADM-selected multidrug-resistant variant of the human myeloma cell line 8226 (Dalton et al., 1986) . The HL-60/MX2 cell line is a mitoxantrone-selected drug-resistant variant of the human leukaemia cell line HL-60 (Harker et al., 1989) . The CEM/VM-l -5 cell line is a VM-26-selected drug-resistant variant of the human leukaemia cell line CEM (Danks et al., 1988) . The WIDR/R cell line is a mitoxantrone-selected drug-resistant variant of the human colon carcinoma cell line WIDR/S . The CHRC5 cell line is a colchicine-selected multidrugresistant variant of the Chinese hamster ovary cell line CHO/ AUXB1 (Ling & Thompson, 1974) . The murine macrophagelike cell line J744.2 and its bleomycin-selected multidrugresistant variant were provided by Dr S. Horwitz (Albert Einstein College of Medicine, New York, NY) and maintained in Dulbecco's modified Eagle's medium with 10% FBS and 1 mm non-essential amino acids.
Unless otherwise indicated, drug-resistant cell lines and their drug-sensitive parental cell lines were obtained directly from the laboratories of origin and cultured according to the conditions described in the references cited. All cell lines were cultured at 37°C in 95% air, 5% CO2 atmosphere and were free of mycoplasma contamination.
Monoclonal antibodies
The production of MAbs 2. 54, 3.50, 3.186, 3.80, 3.177 and 3.187 has been described previously (Mirski & Cole, 1989 Glassy and Surh (1985) as described previously (Mirski & Cole, 1989 Immunoblotting Cells were homogenised in 10 mM Tris-HCl, pH 7.6 buffer containing 10 mM KCl, 1.5 mM MgCl2, 2 mM phenylmethylsulfonyl fluoride (PMSF) and 0.5% Aprotinin (Sigma) at 4°C, and 100,000g membranes were prepared by the method of Gerlach et al. (1987) . Cell membrane preparations in sample buffer without 2-mercaptoethanol (2-ME) were run on sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE) and replica blotted onto Immobolin (Millipore, Mississauga, Ont) by the method of Towbin et al. (1979) . The blot was blocked with 5% FBS/5% NGS/0.05% Tween 20 in PBS (blocking buffer) and then incubated with MAb 2.54 or MAb 3.186 or NS-1 negative control ascites diluted 1:500 in blocking buffer. Binding of the MAbs was detected using alkaline phosphatase-conjugated goat anti-mouse IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) with nitroblue tetrazolium and bromochloroindolyl phosphate (Sigma) as substrates (Mierendorf et al., 1987) .
Immunoprecipitations
MAb ascites, rabbit anti-mouse Igs (DAKO Immunoglobulins, Denmark) and S.aureus (Sigma) were used to immunoprecipitate antigens, as previously described (Mirski & Cole, 1989) , from 100,000g membranes or crude extracts prepared from cells which had been labelled in tissue culture. Alternatively, to reduce non-specific precipitation, protein A Sepharose CL-4B (Pharmacia, Balie d'Urfe, Que) was used and was incubated with rabbit anti-mouse Igs, and MAb ascites and washed prior to use. Immunoprecipitates were washed, boiled 5 min in sample buffer with 2-ME, microfuged, and the supernatant loaded for SDS-PAGE.
Cells were cultured in the presence of 30 pCi ml-' 35S methionine (cell labelling grade, 640-700Cimmol-') (DuPont, Mississauga, Ont) for 24 h in methionine-deficient RPMI 1640 (Sigma) with 10% dialysed FBS or with 750 fCi ml-32P04 (8500-9210 Ci mmol-1) (DuPont) in phosphate-deficient Minimum Essential Medium, Eagle (modified) with Earle's salts (Flow Laboratories, McLean, VA) and 10% dialysed FBS for 2.5 h. An aliquot of 100,000 g membrane containing approximately 2 x 106 acid-precipitable c.p.m. of 35S or 4 x 105 acid-precipitable c.p.m. of 32p was immunoprecipitated.
In some experiments, immunoprecipitates were used for two dimensional electrophoresis as described by O'Farrell et al. (1977) . The first dimension was isoelectric focusing with pH 3 to 10 Ampholines (Pharmacia) or non-equilibrium pH gradient electrophoresis (NEPHGE) in which the pH gradient is reversed. The second dimension was SDS-PAGE. Carbamylated protein standards (Pharmacia) were used to estimate pl. Gels were fixed, those containing 35S were soaked in Amplify (Amersham, Oakville, Ont) and dried. Autoradiographs were obtained with Kodak X-AR film at -70°C.
Enzyme digestions
A glycosidase F preparation containing endoglycosidase F and glycopeptidase F in a 1:1 ratio (Boehringer Mannheim, Indianapolis, IN) was used to hydrolyse hybrid and complex oligosaccharides using conditions recommended by the supplier. Briefly, proteins were denatured by boiling for 3 min with SDS (SDS:protein ratio of 1:1 by weight), and the sample diluted so that the final concentration of SDS in the incubation mix was approximately 1 mg ml' in 0.25 M Na acetate, pH 7 with 0.01% NaN3, 6 mg ml-NP-40, 20 mM EDTA, 10 mM 2-ME, 1 mM PMSF, and 0.5% Aprotinin. Endoglycosidase F was added to a final concentration of 3.4 to 3.6 units ml-', and incubated at 37C for 17 to 19 h.
Negative control digestions were performed in the absence of enzyme. For some experiments 100,000 g membrane preparations of H69AR cells which had been labelled in culture with 35S methionine were digested with the endoglycosidase F preparation and then immunoprecipitated with the MAbs. In other experiments digestions were performed on immunoprecipitates. Digests of fetuin were included in both types of experiment and the increase in its electrophoretic mobility was monitored as a positive control for enzyme activity. (Mirski & Cole, 1989 (Feizi & Childs, 1987) . The inclusion of 2-ME caused the loss of MAb 2.54 antigenicity. In a second approach, 35S methionine-labelled immunoprecipitates were digested with endoglycosidase F and glycopeptidase F and no 
Discussion
The overexpression of P-gp has rarely been detected in tumour samples from patients with SCLC (Lai et al., 1989) , suggesting the P-gp-H69AR cell line may be particularly valuable for studying multidrug resistance in this tumour type. We have produced six MAbs which react selectively with the H69AR cell line compared to its drug sensitive parent, H69 (Mirski & Cole, 1989) . These MAbs define markers associated with the drug resistance phenotype in H69AR cells and possibly in other cell lines as well. The antigen detected by MAb 3.186 is a 36 kDa protein with a pl of 6.7 (Figure lb) . It is phosphorylated (Figure 2 ) but does not contain detectable N-or 0-linked carbohydrates. Multiple proteins of less than 36 kDa are occasionally detected by MAb 3.186 in H69AR cells and in other cell lines (Figures 5 and 6 ). The variability of this observation and the smaller size of these additional proteins suggests that they may be proteolytic degradation products of the larger 36 kDa protein, despite the presence of protease inhibitors in the lysis buffers. Similarly, we believe that the smaller of the two proteins precipitated by MAb 2.54 (25 kDa and 22.5 kDa) may be a degradation product of the larger protein. In addition we found that the 2.54 antigen (pI approximately 7.6) ( Figure 1c) was not detectably phosphorylated or Nglycosylated.
The 55 kDa protein precipitated by MAb 3.50 is acidic (pl approximately 5.7) (Figure la) but does not contain detectable N-linked carbohydrates. Like the 3.186 antigen, the antigen precipitated by MAb 3.50 is phosphorylated. This finding is of interest because the activity of proteins is often regulated by phosphorylation. For example, phosphorylation may have a regulatory role in P-gp-mediated multidrug resistance since Hamada et al. (1987) observed increased phosphorylation of this protein when cells were exposed to agents that inhibit active drug efflux. In addition, Chambers et al. (1990) have shown that phorbol 12-myristate 13-acetate treatment of cells increased both the phosphorylation of P-gp and its activity as indicated by decreased drug accumulation. Further studies are required to determine if the level of phosphorylation of the 3.50 and 3.186 antigens affects the drug resistance phenotype of H69AR cells.
Several observations suggest that MAbs 3.80, 3.177 and 3.187 detect epitopes on the same molecule. Firstly, they all immunoprecipitate 100,000 g membrane-associated proteins of 47 kDa (Mirski & Cole, 1989) . Secondly, these three MAbs react in identical fashion on 14 pairs of drug sensitive and resistant tumour cells in a cell ELISA. Finally, all three MAbs immunoprecipitate proteins of the same size from the drug-resistant cell lines H69AR, MES-SA/MX2 and HT1080/ DR4 and the drug-sensitive cell line WIDR/S (Figure 6 ). Experiments with MAb 3.187, as representative of these three MAbs, have shown that the protein precipitated is not detectably phosphorylated or N-glycosylated.
The biochemical nature of the epitopes with which the MAbs react was determined using a number of techniques. Evidence from digestions with endoglycosidase F and glycopeptidase F and from in vitro translations of H69AR RNA (Figure 3) show that the epitope recognised by MAb 3.186 is a peptide. Determining whether the epitopes detected by MAbs 2.54, 3.50 and 3.187 were peptide or carbohydrate was complicated by their sensitivity to incubation in digestion buffer alone. However the very fact of their sensitivity to this treatment, together with the observations that MAb 2.54 reactivity is lost by boiling in sample buffer with 2-ME (Mirski & Cole, 1989) and MAb 3.50 and 3.187 reactivities are lost by boiling in SDS, suggest that these epitopes are peptides (Feizi & Childs, 1987) . Indeed, the specific immunoprecipitation by MAb 2.54 of a protein from in vitro translation products of H69AR RNA (Figure 3 ) confirms that this epitope is a peptide. The molecular weight of the 2.54 antigen precipitated from in vitro translation products (20.5 kDa) is significantly less than that from H69AR membranes (22.5 kDa and 25 kDa) for reasons that are unclear at the present time (Figure 3 ). However, it is worth noting that it was necessary to allow the 2-ME to evaporate from the in vitro translation mix before an immunoprecipitate could be formed by this MAb and proteolysis might have occurred during this overnight incubation at room temperature. In general, we have observed a progressive decrease in the size of the protein detected by MAb 2.54 as the time the antigen might be exposed to proteases increases, viz., in immunoblots, precipitations from membranes and precipitations from translation products. In further support of this idea, proteins as small as 20.5 kDa were occasionally detected with MAb 2.54 on immunoblots ( Figure 5 ). Because the evidence is unequivocal that epitopes detected by MAbs 2.54 and 3.186 are peptides, these antibodies can be used to screen cDNA expression libraries.
Despite the evidence that there are no N-linked carbohydrates on the antigens and that the epitopes are sensitive to boiling in SDS, we cannot completely eliminate the possibility that the epitopes detected by MAbs 3.50 and 3.187 may be carbohydrate because they did not immunoprecipitate detectable translation products of H69AR RNA. One possible explanation for this result is that the epitopes recognised by these MAbs may not be on the unmodified translation products. The antigens may not assume the appropriate tertiary configuration for recognition because the translation system is not capable of signal peptide cleavage, membrane insertion, or translocation. Alternatively, the 3.50 and 3.187 antigens may not be sufficiently abundant or may contain too few methionine residues to allow detection since they produce weak signals, compared to the other antigens, when precipitated from H69AR membranes. Using a panel of paired drug-sensitive and resistant cell lines, we determined whether the reactions of the MAbs are generally resistance-associated. The panel included representatives of three different drug-resistance phenotypes: eight cell lines that overexpress P-gp, two cell lines that do not overexpress P-gp and five cell lines that do not overexpress P-gp but have cross-resistance patterns not typically associated with the multidrug resistance phenotype (Bradley et al., 1988) . The MAbs did not distinguish among these three groups. Most reactions were either negative or not resistance-associated ' Figure 4) . The ELISA reactions (Figure 4) (Mirski & Cole, 1989) , no resistance-associated reactivity was observed with VIAbs 3.186, 3.50 and 3.187 on the P-gp-human fibrosar-,oma HT1080/DR4 cell line (Figure 4 ). This experiment has )een repeated multiple times over a period of 12 months and )ecause we have consistently found no resistance-associated eactivity, we have greater confidence in the present data. rhe basis for the discrepancy is unknown, but does not tppear to be due to evolution of the drug-sensitive cell line ince HT1080 cells thawed from an early passage also reacted vith the MAbs.
Resistance-associated reactions were observed with MAb !.54 on human ovarian 2780/AD cells and with MAb 3.187 n uterine sarcoma MES-SA/MX2 cells and on the two elated lung carcinoma cell lines IR 500-0 and 2R50; howver, these reactions were relatively weak compared to those )n H69AR cells (Figure 4) . MAb 3.187 reacted in the ELISA ' (Figure 7 ) in a manner consistent with the relative sensitivity of three SCLC cell lines to drugs such as DOX, VP-16, and vinblastine (Campling et al., 1991) . Screening of a larger panel of SCLC cell lines is underway and clearly such studies are required before any comments can be made regarding the significance of this data.
It is interesting to note that the antigens were not overexpressed in the resistant P-gp+ H69/LX4 and H69/DAU4 cell lines (Figure 4 ) nor in the P-gp-SCLC cell line, GLC4/ADR (Dr J. Zijlstra, personal communication). These results indicate that the MAbs will not distinguish all multidrug resistant SCLC cells from sensitive cells and are consistent with the idea that multidrug resistance in this tumour type is heterogeneous (Bergh et al., 1990) . Ultimately, the usefulness of the antibodies must be determined by screening large numbers of clinical samples.
In summary, MAbs 2.54, 3.50, 3.186 and 3.187, raised against the H69AR cell line detect peptide epitopes on four distinct antigens that are also expressed in some other drugsensitive and -resistant cell lines. Proteins with the same biochemical properties and cellular location have not previously been associated with multidrug resistance and thus these proteins are potential novel markers for resistance. However, since the expression of these antigens was often of similar intensity on paired drug-sensitive and -resistant lines and was rarely resistance-associated, they are unlikely to be widely useful as general drug resistance markers. Nevertheless, the possibility remains that these antigens may be markers for several resistance mechanisms; the relative importance of each mechanism may differ in the various cell lines in which drug resistance has a multifactorial basis (Batist et al., 1986; Zijlstra et al., 1987; Deffie et al., 1988) . The cDNA cloning of the antigens described in this study is underway and, once their sequence is known, it should be feasible to synthesise anti-sense oligonucleotides to selectivity turn off expression of each antigen and thereby determine its contribution to the multidrug resistance phenotype observed in the H69AR cell line. 
